Impact of Abciximab in Elderly Patients with High-Risk Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Observational Registry Study

By Iversen Allan Z.   Galatius Soeren   Pedersen Sune   Madsen Jan K.   Jensen Jan S.  

Drugs & Aging, Vol. 28, Iss. 5, 2011-05 ,pp. : 369-378

Adis International

Access to resources Recommend Favorite

Impact of Obstructive Sleep Apnoea on Clinical Characteristics and Outcomes in Patients with Acute Coronary Syndrome Following Percutaneous Coronary Intervention

By Meng S   Fang L   Wang C-Q   Wang L-S   Chen M-T   Huang X-H  

The Journal of International Medical Research, Vol. 37, Iss. 5, 2009-09 ,pp. : 1343-1353

Field House Publishing

Access to resources Recommend Favorite

Current strategies with eptifibatide and other antiplatelet agents in percutaneous coronary intervention and acute coronary syndromes

By Jennings Lisa K  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 727-737

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Use of Intravenous Eptifibatide in Patients Undergoing Percutaneous Coronary Intervention: Acute Coronary Syndromes and Elective Stenting

By Juan F. Granada   Neal S. Kleiman  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 1, 2004-01 ,pp. : 31-41

Adis International

Access to resources Recommend Favorite

Prasugrel: A Guide to Its Use in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in the US

By Lyseng-Williamson Katherine A.  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 3, 2012-06 ,pp. : 207-216

Adis International

Access to resources Recommend Favorite